Skip to main content


Texas Medical Center

Diabetes and Endocrinology
Phone: 832-822-3670
Fax: 832-825-9069


6701 Fannin Street11th Floor
11th Floor
77030 TX
United States

Maria J. Redondo, MD, PhD, MPH

Director of Research

Texas Children's Hospital
Professor of Pediatrics, Pediatric Diabetes & Endocrinology, Baylor College of Medicine


School Education Degree Year
University of Texas School of Public Health masters Master of Public Health 2010
Universidad Complutense de Madrid, Spain PhD Doctor of Philosophy 2005
University of Colorado School of Medicine fellowship Pediatric Endocrinology 2003
Barbara Davis Center for Childhood Diabetes research fellow Type I Diabetes and Autoimmune 1999
Hospital Universitario San Carlos residency Endocrinology 1996
Universidad Automoma de Madrid medical school Doctor of Medicine 1992


My philosophy of care is to provide each child or adolescent with the most advanced medical care, in an individualized and comprehensive manner, to ensure their health and wellbeing. I promote shared decision making with the youth, in an age-appropriate manner, and their family.

My clinical activity focuses in the care of children with diabetes, including type 1, type 2 and other types of diabetes.

The overall goal of my research is the prevention of diabetes and its progression. I am interested in discovering the genetic and environmental causes of diabetes that can be leveraged for prevention and treatment. I also work to understand how to optimize clinical outcomes in pediatric diabetes.

Clinical Interests:

· Diabetes (type 1 diabetes, atypical diabetes, type 2 diabetes, monogenic diabetes, etc.)

Research Interests:

· Prediction and prevention of type 1 diabetes

· Genetics of type 1 diabetes

· Rare and atypical diabetes

· Heterogeneity of diabetes

Active Funded Research Projects:

- Type 1 diabetes genetic risk scores for the diagnosis of diabetes type in children of diverse racial and ethnic background (1R01DK124395-01A1, PI Redondo)

- Type 1 diabetes genetic risk score in TrialNet (NIH 1 R01 DK121843-01, PI Redondo)

- TrialNet Affiliate Clinical Center (NIH, site PI Redondo)

- Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54). Rare and Atypical Diabetes Network (RADIANT) (NIH 1 U54 DK118638-01 , site PI Redondo)

- Enhancement of biomarkers of type 1 diabetes (NIH 2 R01 DK112311-15A1, PI Pietropaolo; Redondo: Co-investigator)

- Addressing Social Needs and Behavioral Health Early in the Type 1 Diabetes Course to Mitigate Inequitable Health Outcomes among Socioeconomically Disadvantaged Minority Youth (BCM, PI Butler; Redondo: Co-investigator)

- Emergency Funding to Support Underserved T1D Populations Impacted by the COVID-19 Pandemic (Helmsley Charitable Trust, PI Redondo)


Organization Name Role
European Association for the Study of Diabetes Member (2014, 2020)
American Diabetes Association Precision Medicine in Diabetes Initiative member (2020-2022); Professional Practice Committee Member (2018/2019); Youth Subcommittee Member (2018-2019); Professional Member (2000-Present)
Diabetes Care Editorial Board Member (2020-Present)
Pediatric Diabetes Editorial Board Member (2017-present) ; Consortium Investigator (2010-2018)
Rare and Atypical Diabetes Network (RADIANT) Investigator (2018-Present)
TrialNet Investigator 2010-Present; Steering Committee Member (2014-2020)
Type 1 Diabetes Exchange Investigator (2010-present)

Selected Publications

Redondo MJ, Evans-Molina C, Steck AK, Atkinson MA, Sosenko J. The influence of type 2 diabetes-associated factors on type 1 diabetes. Diabetes Care 2019 Aug;42(8):1357-1364. PMID: 31167894.

Redondo MJ, Steck AK, Sosenko J, Anderson M, Antinozzi P, Michels A, Wentworth JM, Atkinson MA, Pugliese A, Geyer S; Type 1 Diabetes TrialNet Study Group. Transcription Factor 7-Like 2 (TCF7L2) Gene Polymorphism and Progression From Single to Multiple Autoantibody Positivity in Individuals at Risk for Type 1 Diabetes. Diabetes Care 2018 Dec;41(12):2480-2486. PMID: 30275285.

Redondo MJ, Geyer S, Steck AK, Sharp S, Wentworth JM, Weedon MN, Antinozzi P, Sosenko J, Atkinson M, Pugliese A, Oram RA. A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care 2018 Sep;41(9):1887-1894. PMID: 30002199.

Redondo MJ, Libman I, Cheng P, Kollman C, Tosur M, Gal RL, Bacha F, Klingensmith GJ, Clements M; Pediatric Diabetes Consortium. Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors. Diabetes Care 2018 May;41(5):1017-1024. PMID: 29496742.

Redondo MJ, Geyer S, Steck AK, Sosenko J, Anderson M, Antinozzi P, Michels A, Wentworth J, Xu P, Pugliese A, and the Type 1 Diabetes TrialNet Study Group. TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. Diabetes Care 2018 Feb;41(2):311-317. PMID: 29025879.

View PubMed Publications:


Baylor College of Medicine Pediatrics Research Mentoring Award, 2017

Elected to the Society of Pediatric Research, 2014

Early Career Development Award from the Juvenile Diabetes Foundation, 2002

Postdoctoral Fellowship Award from the Juvenile Diabetes Foundation, 2000

Award for Junior Investigators from the Immunology of Diabetes Society (IDS), 1998

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.